Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
200studies shown
Showing 1-12 of 200
Drug study icon
RecruitingNCT06696755

Adverse Events and Change for Bipolarity

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Huntsville
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
AbbVie
Condition
Bipolarity
Drug study icon
RecruitingNCT06929273

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in France, ...

Multiple locations, including Bentonville
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT07140913

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Argentina, ...

Multiple locations, including Bentonville
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, France, Argentina, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT06951698

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in New Zealand, ...

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Australia, New Zealand, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT06951711

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in China, in Croatia, ...

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, China, Croatia, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT07288320

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolarity type I With Current Mania

This study is looking at care and outcomes for people with Bipolarity I or Mania. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Bipolarity
Drug study icon
RecruitingNCT07286175

Brenipatide in adults with Bipolarity (RENEW-Bipolar-1)

The registry lists this study as recruiting. Study locations are listed in the United States, in Argentina, in Brazil, ...

Multiple locations, including Orange
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 75 Years
Countries
United States, Argentina, Brazil, ...
Sponsor
Eli Lilly and Company
Condition
Bipolarity
Behavioral study icon
RecruitingNCT06920940

Child Bipolar Network Ketogenic Diet Approach to Bipolarity in Adolescents

This study is looking at whether psychoeducation can help people with bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

Multiple locations, including Los Angeles
Why is this study shown?

This study is directly about Bipolarity.

BipolarityBehavioralFrom 12 Years to 21 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Bipolarity
Drug study icon
RecruitingNCT07213466

Individualized Pharmacological Approach to Obesity in people with Bipolarity

This study is looking at whether a digital support tool can help people with bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

In Rochester
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Bipolarity
Behavioral study icon
RecruitingNCT05427123

Children's Bipolar Network Treatment study I

This observational study is following people with bipolarity to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Los Angeles
Why is this study shown?

This study is directly about Bipolarity.

BipolarityBehavioralFrom 9 Years to 19 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Bipolarity
Drug study icon
RecruitingNCT07263191

Olanzapine in people with Bipolarity.

The registry lists this study as recruiting. Study locations are listed in South Korea.

In Seongnam
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugOver 19 Years
Countries
South Korea
Sponsor
Boryung Pharmaceutical Co., Ltd
Condition
Bipolarity
Other study type icon
RecruitingNCT06706687

The Behavioral Variant of Frontotemporal Dementia and Bipolarity: a Neuroimaging and Epigenetics Integrated Approach

The registry lists this study as recruiting. Study locations are listed in Italy.

In Milan
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.Over 18 Years
Countries
Italy
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.